 Home > Medical News > Latest Medical News > Innovent's GLP-1R/GCGR dual agonist treatment of type 2 diabetes phase Ib clinical results announced

Innovent's GLP-1R/GCGR dual agonist treatment of type 2 diabetes phase Ib clinical results announced

 Last Update: 2022-01-12
 Source: Internet
 Author: User

Tags

international petroleum technology conference

glp 1 receptor agonist

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 7, Innovent announced that the glucagon-like peptide-1 receptor (GLP-1R)/glucagon receptor (GCGR) dual agonist IBI362 ( LY3305677) multiple-dose, dose-escalated phase Ib clinical study in Chinese type 2 diabetes patients was accepted by the 2021 International Diabetes Federation Conference (IDF 2021) as a conference abstract and published in the form of an online poster

The study is a randomized, double-blind, placebo-controlled Phase Ib clinical study, which aims to evaluate the safety, tolerability and pharmacokinetics of IBI362 multiple dose escalation administration in Chinese type 2 diabetes patients with poor blood glucose control.

The study was divided into 3 cohorts.

Note: The original text has been deleted

Reference materials:

[1] Ji L, Jiang H, An P, et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.